Table 4.
Name | Established Association with Choroidal Neovascularization |
Possible Mechanism | Possible Use in Clinical Practice |
Reference |
---|---|---|---|---|
EphA7 | Expression in neovascular membranes |
Possible association with the pathogenesis of CNV |
Potential therapeutic target |
[76] |
ephrinB2 and EphB4 | Expression in choroidal endothelial cells Reduction in the leakage score of CNV membranes following intravitreal administration of a soluble form of EphB4 |
Role in maintaining the stability of the vessels Inhibition of choroidal endothelial cells migration |
Potential therapeutic target |
[62] |
EphB4 | Reduction in the leakage score of CNV membranes following intravitreal administration of soluble form of EphB4 Reduction of VEGF following intravitreal administration of a soluble form of EphB4 |
Inhibition of choroidal endothelial cells migration Connection of VEGF and Eph signaling pathways |
Potential therapeutic target |
[77] |
EphB4 | Slowing the progression of CNV following intravitreal administration of EphB4 monoclonal antibody |
Possible association with the pathogenesis of choroidal neovascularization | Potential therapeutic target |
[78] |